A rapid and sensitive bioassay to measure bone morphogenetic protein activity

[1]  Howard Y. Chang,et al.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation , 2006, Proceedings of the National Academy of Sciences.

[2]  M. Yanagita.  Modulator of bone morphogenetic protein activity in the progression of kidney diseases. , 2006, Kidney international.

[3]  P. ten Dijke,et al.  An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct. , 2006, Analytical biochemistry.

[4]  A. Hoffmann,et al.  Development of an enzyme-linked immunoreceptor assay (ELIRA) for quantification of the biological activity of recombinant human bone morphogenetic protein-2. , 2005, Journal of biotechnology.

[5]  Yi Lu,et al.  Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. , 2005, Cancer research.

[6]  D. Keene,et al.  The Prodomain of BMP-7 Targets the BMP-7 Complex to the Extracellular Matrix* , 2005, Journal of Biological Chemistry.

[7]  J. Loscalzo,et al.  Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice , 2005, Circulation.

[8]  F. Luyten,et al.  Bone morphogenetic protein signaling in joint homeostasis and disease. , 2005, Cytokine & growth factor reviews.

[9]  H. von Melchner,et al.  Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung , 2004, The Journal of cell biology.

[10]  J. Lemonnier,et al.  Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation* , 2004, Journal of Biological Chemistry.

[11]  K. Miyazono,et al.  Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells , 2004, The EMBO journal.

[12]  M. Goumans,et al.  Controlling cell fate by bone morphogenetic protein receptors , 2003, Molecular and Cellular Endocrinology.

[13]  Roland Baron,et al.  BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[15]  W. Van Hul,et al.  Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. , 2002, Developmental biology.

[16]  P. ten Dijke,et al.  Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.

[17]  C. Horbinski,et al.  Cerebrospinal Fluid Contains Biologically Active Bone Morphogenetic Protein-7 , 2001, Experimental Neurology.

[18]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[19]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[20]  J. Wrana,et al.  Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[21]  D. Grainger,et al.  TGF-β in blood: a complex problem , 2000 .

[22]  K. Miyazono.  TGF-β signaling by Smad proteins , 2000 .

[23]  D. Constam,et al.  Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases , 1999, The Journal of cell biology.

[24]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[25]  G. Thomas,et al.  BMP‐4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development , 1998, The EMBO journal.

[26]  Ken W. Y. Cho,et al.  Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. , 1997, Development.

[27]  H. Ohuchi,et al.  Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation , 1997, FEBS letters.

[28]  B. Hogan.  Bone morphogenetic proteins in development. , 1996, Current opinion in genetics & development.

[29]  D. Rifkin,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.

[30]  T. Jessell,et al.  Control of cell pattern in the neural tube: Regulation of cell differentiation by dorsalin-1, a novel TGFβ family member , 1993, Cell.

[31]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[32]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[34]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[36]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .

[37]  D. Grainger,et al.  TGF-beta in blood: a complex problem. , 2000, Cytokine & growth factor reviews.

[38]  K. Miyazono.  TGF-beta signaling by Smad proteins. , 2000, Cytokine & growth factor reviews.

[39]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.